ACET Adicet Bio Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ACET

Price (delayed)

$5.62

Market cap

$241.42M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.53

Enterprise value

$33.28M

Adicet Bio, Inc. is a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet is advancing a pipeline of 'off-the-shelf' gamma delta ...

Highlights
The company's net income has shrunk by 192% YoY and by 51% QoQ
ACET's EPS has dropped by 126% year-on-year and by 49% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://www.adicetbio.com
Peers: KWR PFE MRK TEVA

Key stats

What are the main financial stats of ACET
Market
Shares outstanding
42.96M
Market cap
$241.42M
Enterprise value
$33.28M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.91
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$105.21M
EBITDA
-$99.38M
Free cash flow
-$89.03M
Per share
EPS
-$2.53
Free cash flow per share
-$2.07
Book value per share
$6.2
Revenue per share
$0
TBVPS
$6.65
Balance sheet
Total assets
$304.97M
Total liabilities
$38.76M
Debt
$23.5M
Equity
$266.22M
Working capital
$216.71M
Liquidity
Debt to equity
0.09
Current ratio
12.98
Quick ratio
12.8
Net debt/EBITDA
2.09
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-31.9%
Return on equity
-36%
Return on invested capital
-185.7%
Return on capital employed
-36.7%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ACET stock price

How has the Adicet Bio stock price performed over time
Intraday
1.63%
1 week
-10.51%
1 month
-4.75%
1 year
-45.22%
YTD
-37.14%
QTD
-2.43%

Financial performance

How have Adicet Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$110.58M
Net income
-$105.29M
Gross margin
N/A
Net margin
N/A
The company's net income has shrunk by 192% YoY and by 51% QoQ
Adicet Bio's revenue has shrunk by 100% QoQ and by 100% YoY
The gross profit has dropped by 100% since the previous quarter and by 100% year-on-year
ACET's operating income has plunged by 52% from the previous quarter

Growth

What is Adicet Bio's growth rate over time

Valuation

What is Adicet Bio stock price valuation
P/E
N/A
P/B
0.91
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
ACET's EPS has dropped by 126% year-on-year and by 49% since the previous quarter
ACET's price to book (P/B) is 49% lower than its 5-year quarterly average of 1.8 and 39% lower than its last 4 quarters average of 1.5
Adicet Bio's equity has decreased by 14% YoY and by 9% QoQ
Adicet Bio's revenue has shrunk by 100% QoQ and by 100% YoY

Efficiency

How efficient is Adicet Bio business performance
Adicet Bio's return on assets has shrunk by 166% YoY and by 55% QoQ
ACET's ROE has shrunk by 165% YoY and by 57% QoQ
Adicet Bio's ROIC has plunged by 128% YoY and by 47% from the previous quarter

Dividends

What is ACET's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ACET.

Financial health

How did Adicet Bio financials performed over time
ACET's current ratio has dropped by 52% year-on-year and by 2% since the previous quarter
The quick ratio has plunged by 52% YoY and by 2.1% from the previous quarter
Adicet Bio's debt is 91% lower than its equity
ACET's debt to equity is up by 29% QoQ and by 29% YoY
Adicet Bio's equity has decreased by 14% YoY and by 9% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.